Mesenchymal stem cell therapy for severe COVID-19
Perspective
Published on
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 바이오마커, 임상, 치료제,
Journal: Signal Transduction and Targeted Therapy [Category] Fulltext, SARS, 바이오마커, 임상, 치료제,
[키워드] acute respiratory syndrome
acute SARS-CoV-2 infection
adaptive
caused
Characteristics
clinical trial
conducted
coronavirus
coronavirus disease
COVID-19
COVID-19 pandemic
health authorities
highlight
immune disorder
immune regulation
immune tolerance
IMPROVE
Infectious diseases
Inflammatory response
innate immune responses
lung damage
mesenchymal stem cell
MSC
MSC therapy
MSCs
outbreak
pathogenesis of COVID-19
Patient
promote
reduce
regulate
SARS-CoV-2
severe cases
severe COVID-19
significantly
stem cell
Stem-cell research
therapeutic
therapeutic option
therapy
Treatment
Virological
[DOI] 10.1038/s41392-021-00754-6 PMC 바로가기 [Article Type] Perspective
[DOI] 10.1038/s41392-021-00754-6 PMC 바로가기 [Article Type] Perspective